MANGALAM34.88

Mangalam Drugs And Organics Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMLASAVINEETLABORTINGLOBEKREBSBIOALPABALPHARMANATCAPSUQMcap ₹55.2 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation0.016.618.2
+ Finance Costs0.014.916.2
+ Dividend Income0.0-0.0-0.0
+ Fair Value (Gains) / Losses0.0-0.90.0
+ Other Non-cash Items0.00.0-0.6
+ Other Reconciling Items0.00.0-1.1
Changes in Working Capital
+ Inventories0.0-15.236.0
+ Trade Receivables — Current0.0-11.1-1.2
+ Other Financial Assets — Non-current0.00.30.0
+ Other Current Assets0.04.66.6
+ Other Non-current Assets0.00.01.7
+ Trade Payables — Current0.025.0-22.3
+ Other Financial Liabilities — Current0.00.1-3.1
+ Other Financial Liabilities — Non-current0.0-1.6-1.4
+ Other Current Liabilities0.05.57.4
+ Other Non-current Liabilities0.00.0-2.7
+ Provisions — Current0.0-0.4-0.7
Cash from Operating Activities
Profit Before Tax (per I/S)-11.14.8-48.6-55.3
+ Total Adjustments (incl. Working Capital)0.037.953.0
Cash from Operations (pre-tax)-11.142.74.5
+ Income Taxes Paid0.00.10.3
Cash from Operating Activities-11.142.64.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.020.211.9
+ Disp of Fixed Assets0.00.70.2
+ Dividends Received — Investing0.00.00.0
Cash from Investing Activities0.0-19.5-11.7
Cash from Financing Activities
+ Proceeds from Borrowings0.0-6.80.0
+ Repayment of Borrowings0.00.0-21.9
+ Interest Paid0.014.916.2
Cash from Financing Activities0.0-21.75.7
Net Changes in Cash (pre-FX)-11.11.4-1.9
Net Changes in Cash-11.11.4-1.9
Closing Cash-11.1
Reference Items
EBITDA17.435.8-14.9-13.5
EBITDA Margin %4.7211.26-6.42-4.65
Free Cash Flow (CFO − Capex)-11.122.4-7.7-7.7
Free Cash Flow to Equity0.70.4
Free Cash Flow per Basic Share-7.0014.15-4.88-4.88
Cash Flow to Net Income1.226.34-0.09
Cash Paid for Taxes0.00.10.3
Cash Paid for Interest0.014.916.2
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.